Kolexia
Chambost Herve
Pédiatrie
Hôpital La Timone Enfants
Marseille, France
342 Activités
2.5 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Hémophilie B Leucémies Leucémie-lymphome lymphoblastique à précurseurs B et T Maladies de von Willebrand Purpura Troubles de l'hémostase et de la coagulation Syndrome métabolique X

Industries

Sobi
17 collaboration(s)
Dernière en 2023
Roche
3 collaboration(s)
Dernière en 2021
Pfizer
3 collaboration(s)
Dernière en 2023
LFB
1 collaboration(s)
Dernière en 2022

Dernières activités

PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
BMN 270-301: A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients With Residual FVIII Levels ≤ 1 IU/dL Receiving Prophylactic FVIII Infusions
Essai Clinique (BioMarin)   18 décembre 2023
PedNet: The European Paediatric Network for Haemophilia Management and the PedNet Haemophilia Registry
Essai Clinique (PedNet Haemophilia Research Foundation)   26 octobre 2023
Surgery in rare bleeding disorders: the prospective MARACHI study.
Research and practice in thrombosis and haemostasis   06 septembre 2023
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
Journal of thrombosis and haemostasis : JTH   06 septembre 2023
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.
Haemophilia : the official journal of the World Federation of Hemophilia   30 août 2023
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): A multicentric French national observational cross-sectional study based on the FranceCoag registry.
Haemophilia : the official journal of the World Federation of Hemophilia   12 août 2023
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand.
Research and practice in thrombosis and haemostasis   09 août 2023
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis.
Research and practice in thrombosis and haemostasis   07 août 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
European journal of haematology   13 juillet 2023